BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/25/2017 10:21:23 AM | Browse: 1481 | Download: 2557
Publication Name World Journal of Dermatology
Manuscript ID 29650
Country Spain
ISSN 2218-6190 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Dermatology
Manuscript Type Retrospective Study
Article Title Use of a selective enzymatic debridement agent (Nexobrid®) for wound management: Learning curve
Manuscript Source Invited Manuscript
All Author List Ricardo Palao, Jorge Aguilera-Sáez, Jordi Serracanta, Jose Manuel Collado, Bruce Patrik Dos Santos and Juan Pedro Barret
Funding Agency and Grant Number
Corresponding Author Ricardo Palao, MD, Staff Member, Plastic, Reconstructive and Burns Unit Service, Vall d’Hebron University Hospital, Passeig Vall d’Hebron 119-129, 08035 Barcelona, Spain. rpalao@vhebron.net
Key Words Burns; Eschar; Debridement; Enzymatic debride¬ment; Wound bed; Nexobrid®; Epithelialization; Dermis preservation; Autograft
Core Tip Burns continue to be a common injury in western countries. It is difficult to assess the severity of burns, but knowing its mechanisms as well as its characteristics can be of help. An alternative to surgical debridement is the enzymatic or chemical debridement, although past reports that used it with patients show that its efficiency is limited. Nexobrid® is a new enzymatic debridement agent. We show our learning curve with it.
Publish Date 2017-04-25 10:21
Citation Palao R, Aguilera-Sáez J, Serracanta J, Collado JM, Dos Santos BP, Barret JP. Use of a selective enzymatic debridement agent (Nexobrid®) for wound management: Learning curve. World J Dermatol 2017; 6(2): 32-41
URL http://www.wjgnet.com/2218-6190/full/v6/i2/32.htm
DOI http://dx.doi.org/10.5314/wjd.v6.i2.32
Full Article (PDF) WJD-6-32.pdf
Full Article (Word) WJD-6-32.doc